Enanta Pharmaceuticals (ENTA) Cash from Financing Activities (2012 - 2026)
Enanta Pharmaceuticals (ENTA) posted Cash from Financing Activities of -$5.54 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$6.42 million a year earlier.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Cash from Financing Activities (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Enanta Pharmaceuticals was $42.98 million; for FY2025 (ended Sep 30, 2025), it came in at -$26.62 million.
- In prior fiscal years, Enanta Pharmaceuticals' Cash from Financing Activities was -$27.63 million in FY2024, $198.13 million in FY2023 (+889.0%), $20.03 million in FY2022 (+550.4%) and $3.08 million in FY2021 (-65.7%).
- Quarterly Cash from Financing Activities has run from a low of -$8.32 million in fiscal Q4 2025 to a high of $199.88 million in fiscal Q3 2023 over five years.
- According to Business Quant data, Cash from Financing Activities for the three prior fiscal quarters was -$7.3 million (Q2 2026), $64.14 million (Q1 2026) and -$8.32 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Enanta Pharmaceuticals | 383.80 Mn | -344.19 Mn | - | -5.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.54 Mn |
| Mar 31, 2026 | -7.30 Mn |
| Dec 31, 2025 | 64.14 Mn |
| Sep 30, 2025 | -8.32 Mn |
| Jun 30, 2025 | -6.42 Mn |
| Mar 31, 2025 | -6.89 Mn |
| Dec 31, 2024 | -4.99 Mn |
| Sep 30, 2024 | -7.22 Mn |
| Jun 30, 2024 | -6.65 Mn |
| Mar 31, 2024 | -6.41 Mn |
| Dec 31, 2023 | -7.35 Mn |
| Sep 30, 2023 | -23,000.00 |
| Jun 30, 2023 | 199.88 Mn |
| Mar 31, 2023 | -2.03 Mn |
| Dec 31, 2022 | 301,000.00 |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 4.12 Mn |
| Mar 31, 2022 | 3.35 Mn |
| Dec 31, 2021 | 9.63 Mn |
| Sep 30, 2021 | 943,000.00 |
API Access
Enanta Pharmaceuticals Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();